Correction (DOI:10.1016/j.ahj.2006.03.007);Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma

American Heart Journal

Volumn 152, Issue 3, 2006, Pages 478-485

  Donahue, Mark P ^a   Rose, Keith ^b   Hochstrasser, Denis ^b   Vonderscher, Jacky ^d   Grass, Peter ^d   Chibout, Salah Dine ^d   Nelson, Charlotte L ^a   Sinnaeve, Peter ^c   Goldschmidt, Pascal ^a   Granger, Christopher B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; IMMUNOGLOBULIN; LOW DENSITY LIPOPROTEIN; THYROTROPIN; TROPONIN;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ELECTROSPRAY MASS SPECTROMETRY; GROWTH; HUMAN; IMMUNITY; INFLAMMATION; ION EXCHANGE CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RACE DIFFERENCE; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

EID: 33747157431     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.10.001     Document Type: Erratum

References (31)

1. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
2. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106 (2002) 1893-1900
3. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
4. Newby L.K., Storrow A.B., Gibler W.B., et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 103 (2001) 1832-1837
5. Petricoin E.F., Ardekani A.M., Hitt B.A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
6. Anderson N.L., Polanski M., Pieper R., et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3 (2004) 311-326
7. Service R.F. Proteomics. Public projects gear up to chart the protein landscape. Science 302 (2003) 1316-1318
8. Rose K., Bougueleret L., Baussant T., et al. Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics 4 (2004) 2125-2150
9. Rosati R.A., McNeer J.F., Starmer C.F., et al. A new information system for medical practice. Arch Intern Med 135 (1975) 1017-1024
10. Kong D.F., Shaw L.K., and Harrell Jr. F.E. Predicting survival from the coronary arteriogram: an experience-based statistical index of coronary artery disease severity. J Am Coll Cardiol 39 (2002) 327A
11. Colinge J., Masselot A., Cusin I., et al. High-performance peptide identification by tandem mass spectrometry allows reliable automatic data processing in proteomics. Proteomics 4 (2004) 1977-1984
12. Colinge J., Masselot A., Giron M., et al. OLAV: towards high-throughput tandem mass spectrometry data identification. Proteomics 3 (2003) 1454-1463
13. You S.A., Archacki S.R., Angheloiu G., et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics 13 (2003) 25-30
14. Duran M.C., Mas S., Martin-Ventura J.L., et al. Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 3 (2003) 973-978
15. Marshall J., Kupchak P., Zhu W., et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res 2 (2003) 361-372
16. Seifert P.S., Messner M., Roth I., et al. Analysis of complement C3 activation products in human atherosclerotic lesions. Atherosclerosis 91 (1991) 155-162
17. Laine P., Pentikainen M.O., Wurzner R., et al. Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am J Cardiol 90 (2002) 404-408
18. Muscari A., Massarelli G., Bastagli L., et al. Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol 53 (1998) 345-354
19. Muscari A., Bozzoli C., Gerratana C., et al. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74 (1988) 179-186
20. Bdeir K., Cane W., Canziani G., et al. Defensin promotes the binding of lipoprotein (a) to vascular matrix. Blood 94 (1999) 2007-2019
21. Higazi A.A., Lavi E., Bdeir K., et al. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood 89 (1997) 4290-4298
22. Higazi A.A., Nassar T., Ganz T., et al. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood 96 (2000) 1393-1398
23. Juul A., Scheike T., Davidsen M., et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106 (2002) 939-944
24. Ruotolo G., Bavenholm P., Brismar K., et al. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol 35 (2000) 647-654
25. Janssen J.A., Stolk R.P., Pols H.A., et al. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 18 (1998) 277-282
26. Sukhova G.K., Shi G.P., Simon D.I., et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102 (1998) 576-583
27. Sumi Y., Inoue N., Azumi H., et al. Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability. Atherosclerosis 160 (2002) 31-39
28. Lovely R.S., Falls L.A., Al Mondhiry H.A., et al. Association of gammaA/gamma′ fibrinogen levels and coronary artery disease. Thromb Haemost 88 (2002) 26-31
29. McCarthy J.J., Parker A., Salem R., et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 41 (2004) 334-341
30. Stenina O.I., Desai S.Y., Krukovets I., et al. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells. Circulation 108 (2003) 1514-1519
31. Ekmekci H., Sonmez H., Ekmekci O.B., et al. Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. J Thromb Thrombolysis 14 (2002) 221-225